These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12082114)

  • 1. Intramolecular versus intermolecular disulfide bonds in prion proteins.
    Welker E; Raymond LD; Scheraga HA; Caughey B
    J Biol Chem; 2002 Sep; 277(36):33477-81. PubMed ID: 12082114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
    Lee S; Eisenberg D
    Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the disulfide bond in prion protein conversion.
    Herrmann LM; Caughey B
    Neuroreport; 1998 Aug; 9(11):2457-61. PubMed ID: 9721914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for intermolecular disulfide bonds in prion diseases?
    Welker E; Wedemeyer WJ; Scheraga HA
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4334-6. PubMed ID: 11274354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
    Vanik DL; Surewicz WK
    J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility of scrapie-associated prion protein aggregation.
    Callahan MA; Xiong L; Caughey B
    J Biol Chem; 2001 Jul; 276(30):28022-8. PubMed ID: 11375994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide bond as a structural determinant of prion protein membrane insertion.
    Shin JY; Shin JI; Kim JS; Yang YS; Shin YK; Kim KK; Lee S; Kweon DH
    Mol Cells; 2009 Jun; 27(6):673-80. PubMed ID: 19533034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the human prion protein reveals a mechanism for oligomerization.
    Knaus KJ; Morillas M; Swietnicki W; Malone M; Surewicz WK; Yee VC
    Nat Struct Biol; 2001 Sep; 8(9):770-4. PubMed ID: 11524679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro.
    Lawson VA; Priola SA; Meade-White K; Lawson M; Chesebro B
    J Biol Chem; 2004 Apr; 279(14):13689-95. PubMed ID: 14736880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease.
    Zanusso G; Farinazzo A; Fiorini M; Gelati M; Castagna A; Righetti PG; Rizzuto N; Monaco S
    J Biol Chem; 2001 Nov; 276(44):40377-80. PubMed ID: 11682490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
    Lawson VA; Priola SA; Wehrly K; Chesebro B
    J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
    Gill AC; Ritchie MA; Hunt LG; Steane SE; Davies KG; Bocking SP; Rhie AG; Bennett AD; Hope J
    EMBO J; 2000 Oct; 19(20):5324-31. PubMed ID: 11032800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes.
    Tzaban S; Friedlander G; Schonberger O; Horonchik L; Yedidia Y; Shaked G; Gabizon R; Taraboulos A
    Biochemistry; 2002 Oct; 41(42):12868-75. PubMed ID: 12379130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems.
    Raeber AJ; Borchelt DR; Scott M; Prusiner SB
    J Virol; 1992 Oct; 66(10):6155-63. PubMed ID: 1356161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical Characterization of Prions.
    Fiorini M; Bongianni M; Monaco S; Zanusso G
    Prog Mol Biol Transl Sci; 2017; 150():389-407. PubMed ID: 28838671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
    Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion protein oligomer and its neurotoxicity.
    Huang P; Lian F; Wen Y; Guo C; Lin D
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing the solvent accessibility of the prion protein disulfide bond markedly influences its trafficking and effect on cell function.
    Tabrett CA; Harrison CF; Schmidt B; Bellingham SA; Hardy T; Sanejouand YH; Hill AF; Hogg PJ
    Biochem J; 2010 May; 428(2):169-82. PubMed ID: 20337594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form.
    Imamura M; Kato N; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T
    Microbiol Immunol; 2011 Sep; 55(9):633-40. PubMed ID: 21645053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.